Ko­re­an biotech’s shares soar for a 'best of ES­MO' award it nev­er re­ceived

A Ko­re­an biotech an­nounced in Oc­to­ber it had earned recog­ni­tion on a “Best of ES­MO 2019” list – a fact that turned out to be news to ES­MO.

The Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy said yes­ter­day that the biotech, HLB, did not win an award but rather was one in a list of con­fer­ence high­lights that had shown “in­ter­est­ing re­sults,” Bloomberg re­port­ed. HLB’s stock — which had dou­bled in val­ue on the heels of their ES­MO recog­ni­tion — be­gan to trick­le down.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER